Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Current technological advancements in clinical and research settings have permitted a more intensive and comprehensive understanding of Alzheimer’s disease (AD). This development in knowledge regarding AD pathogenesis has been implemented to produce disease-modifying drugs. The potential for accessi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jinny Claire, Kim, Soo Jung, Hong, Seungpyo, Kim, YoungSoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509326/
https://www.ncbi.nlm.nih.gov/pubmed/31073121
http://dx.doi.org/10.1038/s12276-019-0250-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509326/
https://www.ncbi.nlm.nih.gov/pubmed/31073121
http://dx.doi.org/10.1038/s12276-019-0250-2

Ejemplares similares